Your browser doesn't support javascript.
Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?
Bril, Fernando; Al Diffalha, Sameer; Dean, Mark; Fettig, David M.
  • Bril F; Internal Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: fbril@uab.edu.
  • Al Diffalha S; Division of Anatomic Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Dean M; Internal Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Fettig DM; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
J Hepatol ; 75(1): 222-224, 2021 07.
Article in English | MEDLINE | ID: covidwho-1188746
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prednisone / Antibodies, Antinuclear / Hepatitis, Autoimmune / COVID-19 Vaccines / COVID-19 / Liver Type of study: Case report / Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Female / Humans Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prednisone / Antibodies, Antinuclear / Hepatitis, Autoimmune / COVID-19 Vaccines / COVID-19 / Liver Type of study: Case report / Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Female / Humans Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article